
### [MONDO:0004425](http://purl.obolibrary.org/obo/MONDO_0004425)
**Label:** hyperthyroidism

**Subclasses:** [MONDO:0015894](http://purl.obolibrary.org/obo/MONDO_0015894) (rare hyperthyroidism), [MONDO:0019854](http://purl.obolibrary.org/obo/MONDO_0019854) (thyroid ectopia), [MONDO:0009043](http://purl.obolibrary.org/obo/MONDO_0009043) (generalized resistance to thyroid hormone), [MONDO:0019855](http://purl.obolibrary.org/obo/MONDO_0019855) (Athyreosis), [MONDO:0009154](http://purl.obolibrary.org/obo/MONDO_0009154) (hypothyroidism, congenital, Nongoitrous, 5), [MONDO:0019861](http://purl.obolibrary.org/obo/MONDO_0019861) (thyroid hypoplasia), [MONDO:0010131](http://purl.obolibrary.org/obo/MONDO_0010131) (thyroid hormone resistance, generalized, autosomal recessive), [MONDO:0019860](http://purl.obolibrary.org/obo/MONDO_0019860) (thyroid hemiagenesis), [MONDO:0001555](http://purl.obolibrary.org/obo/MONDO_0001555) (neonatal thyrotoxicosis), [MONDO:0001104](http://purl.obolibrary.org/obo/MONDO_0001104) (toxic diffuse goiter), [MONDO:0008569](http://purl.obolibrary.org/obo/MONDO_0008569) (thyroid hormone resistance, generalized, autosomal dominant), [MONDO:0011309](http://purl.obolibrary.org/obo/MONDO_0011309) (familial gestational hyperthyroidism), [MONDO:0007784](http://purl.obolibrary.org/obo/MONDO_0007784) (selective pituitary resistance to thyroid hormone), [MONDO:0001252](http://purl.obolibrary.org/obo/MONDO_0001252) (Plummer's disease), [MONDO:0005364](http://purl.obolibrary.org/obo/MONDO_0005364) (Graves disease), [MONDO:0011314](http://purl.obolibrary.org/obo/MONDO_0011314) (Graves disease, susceptibility to, 2), [MONDO:0012203](http://purl.obolibrary.org/obo/MONDO_0012203) (familial hyperthyroidism due to mutations in TSH receptor), [MONDO:0010138](http://purl.obolibrary.org/obo/MONDO_0010138) (thyrotoxicosis), [MONDO:0010304](http://purl.obolibrary.org/obo/MONDO_0010304) (Graves disease, susceptibility to, X-linked 1), 

**Mapped go classes:** [GO:0060122](http://purl.obolibrary.org/obo/GO_0060122) (inner ear receptor cell stereocilium organization), [GO:0000979](http://purl.obolibrary.org/obo/GO_0000979) (RNA polymerase II core promoter sequence-specific DNA binding), [GO:0039003](http://purl.obolibrary.org/obo/GO_0039003) (pronephric field specification), [GO:0000978](http://purl.obolibrary.org/obo/GO_0000978) (RNA polymerase II proximal promoter sequence-specific DNA binding), [GO:0045762](http://purl.obolibrary.org/obo/GO_0045762) (positive regulation of adenylate cyclase activity), [GO:0008344](http://purl.obolibrary.org/obo/GO_0008344) (adult locomotory behavior), [GO:0072073](http://purl.obolibrary.org/obo/GO_0072073) (kidney epithelium development), [GO:0060005](http://purl.obolibrary.org/obo/GO_0060005) (vestibular reflex), [GO:0004930](http://purl.obolibrary.org/obo/GO_0004930) (G-protein coupled receptor activity), [GO:0003205](http://purl.obolibrary.org/obo/GO_0003205) (cardiac chamber development), [GO:0071371](http://purl.obolibrary.org/obo/GO_0071371) (cellular response to gonadotropin stimulus), [GO:0045893](http://purl.obolibrary.org/obo/GO_0045893) (positive regulation of transcription, DNA-templated), [GO:0001823](http://purl.obolibrary.org/obo/GO_0001823) (mesonephros development), [GO:0072221](http://purl.obolibrary.org/obo/GO_0072221) (metanephric distal convoluted tubule development), [GO:0070324](http://purl.obolibrary.org/obo/GO_0070324) (thyroid hormone binding), [GO:0001947](http://purl.obolibrary.org/obo/GO_0001947) (heart looping), [GO:2000594](http://purl.obolibrary.org/obo/GO_2000594) (positive regulation of metanephric DCT cell differentiation), [GO:0072108](http://purl.obolibrary.org/obo/GO_0072108) (positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis), [GO:1904588](http://purl.obolibrary.org/obo/GO_1904588) (cellular response to glycoprotein), [GO:0090103](http://purl.obolibrary.org/obo/GO_0090103) (cochlea morphogenesis), [GO:0060118](http://purl.obolibrary.org/obo/GO_0060118) (vestibular receptor cell development), [GO:0030819](http://purl.obolibrary.org/obo/GO_0030819) (positive regulation of cAMP biosynthetic process), [GO:0007422](http://purl.obolibrary.org/obo/GO_0007422) (peripheral nervous system development), [GO:0060119](http://purl.obolibrary.org/obo/GO_0060119) (inner ear receptor cell development), [GO:0043235](http://purl.obolibrary.org/obo/GO_0043235) (receptor complex), [GO:0005886](http://purl.obolibrary.org/obo/GO_0005886) (plasma membrane), [GO:0090190](http://purl.obolibrary.org/obo/GO_0090190) (positive regulation of branching involved in ureteric bud morphogenesis), [GO:0005634](http://purl.obolibrary.org/obo/GO_0005634) (nucleus), [GO:0007417](http://purl.obolibrary.org/obo/GO_0007417) (central nervous system development), [GO:0005515](http://purl.obolibrary.org/obo/GO_0005515) (protein binding), [GO:0046872](http://purl.obolibrary.org/obo/GO_0046872) (metal ion binding), [GO:0010667](http://purl.obolibrary.org/obo/GO_0010667) (negative regulation of cardiac muscle cell apoptotic process), [GO:0040012](http://purl.obolibrary.org/obo/GO_0040012) (regulation of locomotion), [GO:0008284](http://purl.obolibrary.org/obo/GO_0008284) (positive regulation of cell proliferation), [GO:0044212](http://purl.obolibrary.org/obo/GO_0044212) (transcription regulatory region DNA binding), [GO:0045944](http://purl.obolibrary.org/obo/GO_0045944) (positive regulation of transcription by RNA polymerase II), [GO:0043401](http://purl.obolibrary.org/obo/GO_0043401) (steroid hormone mediated signaling pathway), [GO:0040018](http://purl.obolibrary.org/obo/GO_0040018) (positive regulation of multicellular organism growth), [GO:0007507](http://purl.obolibrary.org/obo/GO_0007507) (heart development), [GO:0004996](http://purl.obolibrary.org/obo/GO_0004996) (thyroid-stimulating hormone receptor activity), [GO:0003700](http://purl.obolibrary.org/obo/GO_0003700) (DNA binding transcription factor activity), [GO:0043010](http://purl.obolibrary.org/obo/GO_0043010) (camera-type eye development), [GO:0003707](http://purl.obolibrary.org/obo/GO_0003707) (steroid hormone receptor activity), [GO:0007190](http://purl.obolibrary.org/obo/GO_0007190) (activation of adenylate cyclase activity), [GO:0003281](http://purl.obolibrary.org/obo/GO_0003281) (ventricular septum development), [GO:0061626](http://purl.obolibrary.org/obo/GO_0061626) (pharyngeal arch artery morphogenesis), [GO:0048703](http://purl.obolibrary.org/obo/GO_0048703) (embryonic viscerocranium morphogenesis), [GO:0048793](http://purl.obolibrary.org/obo/GO_0048793) (pronephros development), [GO:0004887](http://purl.obolibrary.org/obo/GO_0004887) (thyroid hormone receptor activity), [GO:0003677](http://purl.obolibrary.org/obo/GO_0003677) (DNA binding), [GO:0001655](http://purl.obolibrary.org/obo/GO_0001655) (urogenital system development), [GO:0030878](http://purl.obolibrary.org/obo/GO_0030878) (thyroid gland development), [GO:0001656](http://purl.obolibrary.org/obo/GO_0001656) (metanephros development), [GO:0071542](http://purl.obolibrary.org/obo/GO_0071542) (dopaminergic neuron differentiation), [GO:0016500](http://purl.obolibrary.org/obo/GO_0016500) (protein-hormone receptor activity), [GO:0048839](http://purl.obolibrary.org/obo/GO_0048839) (inner ear development), [GO:0034672](http://purl.obolibrary.org/obo/GO_0034672) (anterior/posterior pattern specification involved in pronephros development), [GO:1900212](http://purl.obolibrary.org/obo/GO_1900212) (negative regulation of mesenchymal cell apoptotic process involved in metanephros development), [GO:0038194](http://purl.obolibrary.org/obo/GO_0038194) (thyroid-stimulating hormone signaling pathway), [GO:1905229](http://purl.obolibrary.org/obo/GO_1905229) (cellular response to thyrotropin-releasing hormone), [GO:0060840](http://purl.obolibrary.org/obo/GO_0060840) (artery development), [GO:1900215](http://purl.obolibrary.org/obo/GO_1900215) (negative regulation of apoptotic process involved in metanephric collecting duct development), [GO:1900218](http://purl.obolibrary.org/obo/GO_1900218) (negative regulation of apoptotic process involved in metanephric nephron tubule development), [GO:0009755](http://purl.obolibrary.org/obo/GO_0009755) (hormone-mediated signaling pathway), [GO:0005667](http://purl.obolibrary.org/obo/GO_0005667) (transcription factor complex), [GO:0001077](http://purl.obolibrary.org/obo/GO_0001077) (transcriptional activator activity, RNA polymerase II proximal promoter sequence-specific DNA binding), [GO:0003007](http://purl.obolibrary.org/obo/GO_0003007) (heart morphogenesis), [GO:0001076](http://purl.obolibrary.org/obo/GO_0001076) (transcription factor activity, RNA polymerase II transcription factor binding), [GO:0072305](http://purl.obolibrary.org/obo/GO_0072305) (negative regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis), [GO:0032403](http://purl.obolibrary.org/obo/GO_0032403) (protein complex binding), [GO:0055007](http://purl.obolibrary.org/obo/GO_0055007) (cardiac muscle cell differentiation), [GO:0072307](http://purl.obolibrary.org/obo/GO_0072307) (regulation of metanephric nephron tubule epithelial cell differentiation), [GO:0008270](http://purl.obolibrary.org/obo/GO_0008270) (zinc ion binding), [GO:0007186](http://purl.obolibrary.org/obo/GO_0007186) (G-protein coupled receptor signaling pathway), [GO:0030183](http://purl.obolibrary.org/obo/GO_0030183) (B cell differentiation), [GO:0042981](http://purl.obolibrary.org/obo/GO_0042981) (regulation of apoptotic process), [GO:0007189](http://purl.obolibrary.org/obo/GO_0007189) (adenylate cyclase-activating G-protein coupled receptor signaling pathway), [GO:0046549](http://purl.obolibrary.org/obo/GO_0046549) (retinal cone cell development), [GO:0004872](http://purl.obolibrary.org/obo/GO_0004872) (receptor activity), [GO:0060038](http://purl.obolibrary.org/obo/GO_0060038) (cardiac muscle cell proliferation), [GO:0004871](http://purl.obolibrary.org/obo/GO_0004871) (signal transducer activity), [GO:0009887](http://purl.obolibrary.org/obo/GO_0009887) (animal organ morphogenesis), [GO:0000790](http://purl.obolibrary.org/obo/GO_0000790) (nuclear chromatin), [GO:0042472](http://purl.obolibrary.org/obo/GO_0042472) (inner ear morphogenesis), [GO:0016323](http://purl.obolibrary.org/obo/GO_0016323) (basolateral plasma membrane), [GO:0007275](http://purl.obolibrary.org/obo/GO_0007275) (multicellular organism development), [GO:0007399](http://purl.obolibrary.org/obo/GO_0007399) (nervous system development), [GO:0043565](http://purl.obolibrary.org/obo/GO_0043565) (sequence-specific DNA binding), [GO:0003231](http://purl.obolibrary.org/obo/GO_0003231) (cardiac ventricle development), [GO:0043049](http://purl.obolibrary.org/obo/GO_0043049) (otic placode formation), [GO:0072050](http://purl.obolibrary.org/obo/GO_0072050) (S-shaped body morphogenesis), [GO:0005654](http://purl.obolibrary.org/obo/GO_0005654) (nucleoplasm), [GO:0072164](http://purl.obolibrary.org/obo/GO_0072164) (mesonephric tubule development), [GO:0005887](http://purl.obolibrary.org/obo/GO_0005887) (integral component of plasma membrane), [GO:0072289](http://purl.obolibrary.org/obo/GO_0072289) (metanephric nephron tubule formation), [GO:2000611](http://purl.obolibrary.org/obo/GO_2000611) (positive regulation of thyroid hormone generation), [GO:2000612](http://purl.obolibrary.org/obo/GO_2000612) (regulation of thyroid-stimulating hormone secretion), [GO:0006351](http://purl.obolibrary.org/obo/GO_0006351) (transcription, DNA-templated), [GO:0007165](http://purl.obolibrary.org/obo/GO_0007165) (signal transduction), [GO:1901210](http://purl.obolibrary.org/obo/GO_1901210) (regulation of cardiac chamber formation), [GO:0006355](http://purl.obolibrary.org/obo/GO_0006355) (regulation of transcription, DNA-templated), [GO:0007166](http://purl.obolibrary.org/obo/GO_0007166) (cell surface receptor signaling pathway), [GO:0035050](http://purl.obolibrary.org/obo/GO_0035050) (embryonic heart tube development), [GO:0002154](http://purl.obolibrary.org/obo/GO_0002154) (thyroid hormone mediated signaling pathway), [GO:0008528](http://purl.obolibrary.org/obo/GO_0008528) (G-protein coupled peptide receptor activity), [GO:0045121](http://purl.obolibrary.org/obo/GO_0045121) (membrane raft), [GO:0016020](http://purl.obolibrary.org/obo/GO_0016020) (membrane), [GO:0030154](http://purl.obolibrary.org/obo/GO_0030154) (cell differentiation), [GO:0016021](http://purl.obolibrary.org/obo/GO_0016021) (integral component of membrane), 

**Class expressions from DL-Learner:**

- Thing 54.14%
- [GO:0060038](http://purl.obolibrary.org/obo/GO_0060038) (cardiac muscle cell proliferation) 51.19%
- [GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process) 46.49%
- [GO:0033002](http://purl.obolibrary.org/obo/GO_0033002) (muscle cell proliferation) 36.55%
- [GO:0014855](http://purl.obolibrary.org/obo/GO_0014855) (striated muscle cell proliferation) 36.55%
- [GO:0014855](http://purl.obolibrary.org/obo/GO_0014855) (striated muscle cell proliferation) and ([GO:0006129](http://purl.obolibrary.org/obo/GO_0006129) (obsolete protein-disulfide reduction) or [GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process)) 36.55%
- [GO:0014855](http://purl.obolibrary.org/obo/GO_0014855) (striated muscle cell proliferation) and ([GO:0006128](http://purl.obolibrary.org/obo/GO_0006128) (obsolete oxidized glutathione reduction) or [GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process)) 36.55%
- [GO:0014855](http://purl.obolibrary.org/obo/GO_0014855) (striated muscle cell proliferation) and ([GO:0006126](http://purl.obolibrary.org/obo/GO_0006126) (obsolete other pathways of electron transport) or [GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process)) 36.55%
- [GO:0014855](http://purl.obolibrary.org/obo/GO_0014855) (striated muscle cell proliferation) and ([GO:0006125](http://purl.obolibrary.org/obo/GO_0006125) (obsolete thioredoxin pathway) or [GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process)) 36.55%
- [GO:0014855](http://purl.obolibrary.org/obo/GO_0014855) (striated muscle cell proliferation) and ([GO:0006118](http://purl.obolibrary.org/obo/GO_0006118) (obsolete electron transport) or [GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process)) 36.55%
- [GO:0014855](http://purl.obolibrary.org/obo/GO_0014855) (striated muscle cell proliferation) and ([GO:0006100](http://purl.obolibrary.org/obo/GO_0006100) (obsolete tricarboxylic acid cycle intermediate metabolic process) or [GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process)) 36.55%
- [GO:0014855](http://purl.obolibrary.org/obo/GO_0014855) (striated muscle cell proliferation) and ([GO:0006095](http://purl.obolibrary.org/obo/GO_0006095) (null) or [GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process)) 36.55%
- [GO:0014855](http://purl.obolibrary.org/obo/GO_0014855) (striated muscle cell proliferation) and ([GO:0006093](http://purl.obolibrary.org/obo/GO_0006093) (null) or [GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process)) 36.55%
- [GO:0014855](http://purl.obolibrary.org/obo/GO_0014855) (striated muscle cell proliferation) and ([GO:0006092](http://purl.obolibrary.org/obo/GO_0006092) (null) or [GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process)) 36.55%
- [GO:0014855](http://purl.obolibrary.org/obo/GO_0014855) (striated muscle cell proliferation) and ([GO:0006088](http://purl.obolibrary.org/obo/GO_0006088) (obsolete acetate to acetyl-CoA) or [GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process)) 36.55%


